BC Innovations | Dec 3, 2015
Product R&D

Eyeing fewer needles

Eyevensys S.A.S. is creating a non-viral gene therapy platform for ophthalmic diseases that can deliver steady, low levels of therapeutic protein to the eye for up to a year with a single treatment. Having raised...
Items per page:
1 - 1 of 1